Mutabilis

About:

Mutabilis is discovery of new therapeutic targets for the development of anti-infectives.

Website: https://mutabilis.fr/

Top Investors: Omnes Capital, CARB-X, Repair Impact Fund

Description:

Mutabilis is discovery of new therapeutic targets for the development of anti-infectives. Mutabilis is a biopharmaceutical company specialised in the discovery and development of anti-infectives. Mutabilis discovers and develops innovative anti-infectives, a novel class of drug addressing the current issues arising from resistance to antibiotics and targeting severe bacterial infections. Mutabilis’ new therapies target nosocomial infections in particular.